BrightSpring Q3 prelim rev up 28% YoY; raises FY 2025 guidance

BrightSpring Health Services, Inc.

2025-Q3 EPS reported $0.52 revenue$9,359,933,000

Preliminary Q3 revenue ~$3,334M (+28.2% YoY); net income $37.5M vs loss $25.7M.
Adj. EBITDA ~$160M (+37.2% YoY); gross profit $392M (+21.3%).
FY 2025 guidance raised: revenue $12.4B-$12.7B (23-26% growth); Adj. EBITDA $605M-$615M.
Pharmacy segment revenue guided to $10.95B-$11.2B; Provider segment $1.45B-$1.5B.
Community Living divestiture to Sevita expected close early Q1 2026; leverage 3.31x.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.